CellCarta’s Center of Excellence for development of complex genomic biomarker assays located in Ghent (Belgium) was the first European laboratory to commercially offer the dPCR technology and is still at the forefront of digital PCR-based research.
As expert dPCR service provider, our team supports any dPCR-based application, using either off-the-shelf assays or including custom primer design, all performed in an ISO 17025 accredited environment. We developed a close collaboration with Bio-Rad and are using Bio‑Rad’s QX200™ Digital Droplet PCR™ technology.
dPCR enables nucleic acid quantification with superior accuracy, precision and relative sensitivity. This technology excels in:
As absolute concentrations are determined, data can be easily interpreted and compared across different samples and experiments, especially in a clinical setting.
Digital PCR leads to absolute quantification and does not require the use of standard curves as qPCR. The assay particularly excels in providing the quantification of low abundant targets or small differences.
Learn more about the intrinsic potential our digital droplet PCR (ddPCR) assays in clinical studies with 4 applications performed by our team:
Our team is setting standards in the field of dPCR through participation in the development of guidelines and key scientific publications: